Invesco Ltd. Cogent Biosciences, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 494,078 shares of COGT stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

494,078

Previous 163,966 201.33%

Holding current value

$4.05 Million

Previous $1.38 Million 286.11%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.24 - $11.48 $2.72 Million - $3.79 Million	330,112 Added 201.33%	494,078 $5.34 Million
Q2 2024 Aug 13, 2024	BUY	$6.01 - $9.04 $764,015 - $1.15 Million	127,124 Added 345.05%	163,966 $1.38 Million
Q1 2024 May 14, 2024	BUY	$4.38 - $9.02 $9,206 - $18,960	2,102 Added 6.05%	36,842 $247,000
Q4 2023 Feb 12, 2024	BUY	$4.06 - $10.08 $8,387 - $20,825	2,066 Added 6.32%	34,740 $204,000
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $13,207 - $18,182	1,363 Added 4.35%	32,674 $318,000
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.24 $36,415 - $48,948	3,697 Added 13.39%	31,311 $370,000
Q1 2023 May 12, 2023	BUY	$10.04 - $15.5 $100,389 - $154,984	9,999 Added 56.76%	27,614 $297,000
Q4 2022 Feb 13, 2023	SELL	$10.65 - $14.84 $4.68 Million - $6.53 Million	-439,868 Reduced 96.15%	17,615 $203,000
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $4.1 Million - $7.41 Million	-436,109 Reduced 48.8%	457,483 $6.83 Million
Q2 2022 Aug 15, 2022	BUY	$3.92 - $9.73 $3.45 Million - $8.58 Million	881,334 Added 7189.87%	893,592 $8.06 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.7 $2,437 - $3,993	459 Added 3.89%	12,258 $92,000
Q4 2021 Feb 14, 2022	SELL	$7.51 - $10.81 $2,523 - $3,632	-336 Reduced 2.77%	11,799 $102,000
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $4.3 Million - $6.56 Million	-717,711 Reduced 98.34%	12,135 $102,000
Q2 2021 Aug 17, 2021	BUY	$7.82 - $9.3 $209,278 - $248,886	26,762 Added 3.81%	729,846 $5.92 Million
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $23,037 - $38,056	3,084 Added 0.44%	703,084 $6.17 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $6.33 Million - $9.11 Million	700,000 New	700,000 $7.86 Million

Others Institutions Holding COGT

# of Institutions

172

Shares Held

114M

Call Options Held

56.7K

Put Options Held

40.4K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $539M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account